These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3461893)

  • 21. Abnormal collagen metabolism in cultured skin fibroblasts from patients with Duchenne muscular dystrophy.
    Rodemann HP; Bayreuther K
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5130-4. PubMed ID: 6591184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic membrane defect in the proximal muscular dystrophies.
    Pickard NA; Gruemer HD; Verrill HL; Isaacs ER; Robinow M; Nance WE; Myers EC; Goldsmith B
    N Engl J Med; 1978 Oct; 299(16):841-6. PubMed ID: 308614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duchenne muscular dystrophy manifesting carriers.
    Barkhaus PE; Gilchrist JM
    Arch Neurol; 1989 Jun; 46(6):673-5. PubMed ID: 2730379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kinetics of cell-substratum detachment mediated by trypsin: a comparison of normal and Duchenne fibroblasts.
    Simon LV; Pizzey JA; Jones GE
    J Cell Sci; 1989 Feb; 92 ( Pt 2)():257-62. PubMed ID: 2777925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blind evaluation of lymphocyte capping in Duchenne muscular dystrophy.
    Goldsmith BM; Drachman DB; Gruemer HD; Miller WG; Self SS
    Neurology; 1984 Jun; 34(6):821-4. PubMed ID: 6374498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duchenne muscular dystrophy: lack of differences in the expression of endogenous carbohydrate- and heparin-binding proteins (lectins) in cultured fibroblasts.
    Stulnig T; Schweiger M; Hirsch-Kauffmann M
    Eur J Cell Biol; 1993 Oct; 62(1):173-81. PubMed ID: 8269975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Freeze-fracture analysis of plasma membranes in Duchenne muscular dystrophy. A study using cultured skin fibroblasts.
    Jones GE; Severs NJ; Witkowski JA
    J Neurol Sci; 1983 Feb; 58(2):185-93. PubMed ID: 6300339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased membrane permeability to chloride in Duchenne muscular dystrophy fibroblasts and its relationship to muscle function.
    Pato CN; Davis MH; Doughty MJ; Bryant SH; Gruenstein E
    Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4732-6. PubMed ID: 6576355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased structure-linked latency of lysosomal dipeptidyl aminopeptidase-I activity in Duchenne muscular dystrophy fibroblasts.
    Davis MH; Gelman BB; Gruenstein E
    Neurology; 1982 May; 32(5):486-91. PubMed ID: 7200205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Freeze-fracture study of muscle plasma membrane in obligate carriers of Duchenne muscular dystrophy.
    Bonilla E; Fischbeck KH; Schotland DL
    Neurology; 1983 Oct; 33(10):1346-7. PubMed ID: 6684233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.
    Bonilla E; Schmidt B; Samitt CE; Miranda AF; Hays AP; de Oliveira AB; Chang HW; Servidei S; Ricci E; Younger DS
    Am J Pathol; 1988 Dec; 133(3):440-5. PubMed ID: 3059802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proline incorporation by cultured skin fibroblasts from patients with duchenne muscular dystrophy.
    Thompson RG; Sponder ES; Rosenmann E; Hamerton JL; Wrogemann K
    J Neurol Sci; 1982; 57(1):41-54. PubMed ID: 7153783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of insulin resistance and decreased insulin receptor binding in Duchenne muscular dystrophy.
    Freidenberg GR; Olefsky JM
    J Clin Endocrinol Metab; 1985 Feb; 60(2):320-7. PubMed ID: 3965491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribosomal protein synthesis in cultured skin fibroblast cells obtained from patients with Duchenne muscular dystrophy.
    Pöche H; Schulze H
    J Neurol Sci; 1985 Oct; 70(3):295-304. PubMed ID: 4056825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A two-year-old clinically manifesting carrier of Duchenne muscular dystrophy].
    Yamamoto T; Kawahara H; Inagaki M; Ohta S
    No To Hattatsu; 1991 Jul; 23(4):384-8. PubMed ID: 1873056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
    Verrill HL; Pickard NA; Gruemer HD
    Clin Chem; 1977 Dec; 23(12):2341-3. PubMed ID: 923085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective Ca2+ metabolism in Duchenne muscular dystrophy: effects on cellular and viral growth.
    Fingerman E; Campisi J; Pardee AB
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7617-21. PubMed ID: 6095311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of carriers of human Duchenne muscular dystrophy by freeze-fracture analysis of erythrocyte plasmalemmal intramembrane particles.
    Shivers RR; Martin K; Atkinson BG
    Am J Clin Pathol; 1986 Feb; 85(2):131-4. PubMed ID: 3946298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrin extractability from erythrocytes in Duchenne muscular dystrophy patients and carriers and in other myopathies.
    Gargioni G; Chiaffoni G; Bonadonna G; Corradini P; Lechi C; de Grandis D; Zatti M
    Clin Chim Acta; 1985 Feb; 145(3):259-65. PubMed ID: 3987029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on correlation between HLA-A, B, DR alleles and Duchenne muscular dystrophy].
    Chen W; Xiao L; Zhang C; Wu HL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):567-70. PubMed ID: 17922429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.